Results 311 to 320 of about 308,666 (390)

Rethinking vasopressor use in the trauma bay: a shifting perspective. [PDF]

open access: yesTrauma Surg Acute Care Open
Burke EG   +3 more
europepmc   +1 more source

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Venetoclax is a potent, oral BCL‐2 inhibitor approved as combination therapy for the treatment of adults with newly diagnosed acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy. This study evaluated the safety and preliminary efficacy of venetoclax alone or combined with chemotherapy in paediatric and ...
Seth E. Karol   +29 more
wiley   +1 more source

Horner syndrome in a pediatric patient

open access: yesPediatric Investigation, EarlyView.
Horner syndrome (HS) is a rare neurological disorder arising from disruption of the oculosympathetic pathway. paediatric HS is uncommon and may be congenital, however it is imperative that underlying sinister causes are excluded. ABSTRACT Introduction Horner syndrome (HS) is a rare neurological disorder arising from disruption of the oculosympathetic ...
Devansh Tandon   +4 more
wiley   +1 more source

Deep learning model to identify and validate hypotension endotypes in surgical and critically ill patients. [PDF]

open access: yesBr J Anaesth
Jian Z   +15 more
europepmc   +1 more source

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
Abstract Introduction Treatment of infections in patients with burn injuries is challenging due to altered antimicrobial pharmacokinetics. Continuous infusion β‐lactam therapy may be a useful antimicrobial stewardship strategy to improve pharmacodynamic target attainment in this population.
Jay D. Olivet   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy